secwatch.observer — SEC 8-K summary
======================================

Issuer:     FENNEC PHARMACEUTICALS INC. (FENC)
CIK:        0001211583
Form:       8-K
Filed at:   2022-01-31T23:59:59+00:00
Accession:  0001104659-22-009274
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fennec amends loan agreement with Bridge Bank; sets PEDMARK NDA resubmission and approval milestones
--------------------------------------------------------------------------------

- Third Amendment to 2019 Loan & Security Agreement with Bridge Bank (Western Alliance Bank) dated Jan 27, 2022.
- Defines 'Resubmission Event': resubmission of PEDMARK NDA to FDA on or before March 31, 2022.
- Defines 'Approval Event': receipt of final NDA approval for PEDMARK on or before September 30, 2022.
- Second Draw Period commences upon Approval Event; proceeds for commercial readiness prior to potential PEDMARK approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1211583/000110465922009274/0001104659-22-009274-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1211583/000110465922009274/tm224898d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-009274

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer